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Background and purpose   Little is known about the long-term 
outcome of cemented metal-on-metal hip arthroplasties. We eval-
uated a consecutive series of metal-on-metal polyethylene-backed 
cemented hip arthroplasties implanted in patients under 60 years 
of age. 
Methods   109 patients (134 joint replacements) were followed 
prospectively for mean 9 (7–11) years. The evaluation included 
clinical score, radiographic assessment, and blood sampling for 
ion level determination. 
Results   At the final review, 12 hips had been revised, mainly 
because of aseptic loosening of the socket. Using revision for asep-
tic loosening as the endpoint, the survival rate at 9 years was 91% 
for the cup and 99% for the stem. In addition, 35 hips showed 
radiolucent lines at the bone-cement interface of the acetabulum 
and  some  were  associated  with  osteolysis.  The  median  serum 
cobalt and chromium levels were relatively constant over time, 
and were much higher than the detection level throughout the 
study period. The cobalt level was 1.5 µg/L 1 year after implanta-
tion, and 1.44 µg/L 9 years after implantation. 
Interpretation   Revisions for aseptic loosening and radiographic 
findings in the sockets led us to halt metal-on-metal-backed poly-
ethylene cemented hip arthroplasty procedures. If the rigidity of 
the cemented socket is a reason for loosening, excessive release of 
metal ions and particles may be involved. Further investigations are 
required to confirm this hypothesis and to determine whether sub-
luxation, microseparation, and hypersensitivity also play a role.

 
The second generation of metal-on-metal (MM) prostheses 
appeared in the late 1980s as a response to concerns about 
wear and complications associated with polyethylene, such as 
periprosthetic bone loss and aseptic loosening (Wroblewski et 
al. 1996). The second generation of MM prostheses for total 
hip arthroplasty (THA) had improved metallurgy, design, and 
precision in terms of the manufacture of the bearing surfaces 
(Weber 1996, Rieker et al. 2004). Early analysis of retrievals 
and wear simulation data indicated that the second generation 
of MM prostheses had minimal linear and volumetric wear 
after a run-in phase (Rieker et al. 2004). Short-term clinical 
results have also been encouraging (Weber 1996, Saito et al. 
2006). 
There are concerns about MM prostheses, because they gen-
erate chromium and cobalt ions and particles (Brodner et al. 
2003, Rasquinha et al. 2006). In addition to problems related to 
tribology, questions remain about appropriate patient selection 
and about the medium- and long-term survival of cemented 
MM implants (Park et al. 2005, Catelas et al. 2006, Levai et 
al. 2006, Nich et al. 2006, Brown et al. 2007). 
The purpose of this prospective study was to present data 
from  the  second  generation  of  MM-backed  polyethylene 
cemented hip prostheses at a mean follow-up time of 9 years. 
We conducted clinical and radiographic assessments as well 
as determination of serum cobalt, chromium, and titanium.
Patients and methods
From January 1997 through December 2000, we prospectively 
followed a series of 113 consecutive patients at our institution 
who underwent primary total hip replacements (THA) using 
the Metasul Hip System (Zimmer, Warsaw, IN). 
All patients provided informed written consent for this long-
term clinical and biological prospective study. In accordance 
with the practice of the ethics board at our institution, they 
received complete information about the study, including the 
goals and the procedures for blood sampling. 
Exclusion  criteria  were  the  presence  of  other  orthopedic 
implants, a history of professional or dental exposure to tita-
nium or cobalt, previous conservative surgical procedures on 
either hip, or renal disease. All enrolled patients were below 
60 years of age at the time of surgery. In our practice, fewer 
than 20% of all patients undergoing primary THA during the 
study period were eligible for inclusion in this study.Acta Orthopaedica 2009; 80 (2): 168–173  169
Mean age at the time of arthroplasty was 54 (30–60) years. 
53 females and 56 males were included. The etiologies were 
primary  arthritis  (121  cases)  and  osteonecrosis  (13  cases). 
Mean body mass index was 26 (19–34). During the preop-
erative period, 77% of patients had an activity level graded 
as 4 or 5 according to the Devane activity score (Devane and 
Horne 1999). Clinical data for each patient were obtained by 
office interview and physical examination before surgery, and 
at each follow-up examination. Hip function results were rated 
using the Harris hip score grading system.
Of the 113 patients (138 hips), 4 patients (4 hips) were lost 
to follow-up in the first 5 years. At their last review, they had 
no pain and none had loosened implants. 
The remaining 109 patients (134 hips) were available for 
complete clinical and radiographic analysis 7–11 years post-
operatively. No patients in the series died.
Implant characteristics
We used cemented Metasul cups (Zimmer, Warsaw, IN) for 
all replacements. This cup is composed of a single compo-
nent, namely a 3-mm thick cobalt-chromium (Co-Cr) inlay 
embedded in a polyethylene socket. The cemented femoral 
stem (Alizé; Fournitures Hospitalières, Quimper, France) is 
collarless, oval in cross section, and straight. The implant was 
made of titanium alloy (Ti-6Al-4V) with a polished surface 
coated with titanium oxide (TiO2) obtained by anodization. 6 
stem sizes were available. The modular stem was combined 
with a 28-mm Metasul femoral head (Zimmer) with a 12/14, 
5°43’ taper. 
Head-neck compatibility was assessed by a unitary control 
for the taper angle (precision: 1 minute) and by the diame-
ter at the base and the diameter at the summit (precision: 1 
micron) (Pexit Dorsey Gage, Cambridge, UK). Palacos Genta 
cement (Scherring Plough, Brussels, Belgium) was used for 
both components.
Surgery
All procedures were performed following the standard prac-
tice at our institution, namely using an anterior approach on 
a Judet orthopedic table, by 4 different surgeons. To obtain 
a complete and thick cement mantle, the femoral canal was 
over-reamed by 2 mm and distally occluded by a resorbable 
femoral plug (Synplug; Zimmer). The cement was injected 
in  retrograde  fashion  and  pressurized  by  a  hand-driven 
syringe.
Radiographic assessment
Anteroposterior and lateral radiographs of each hip were taken 
before and immediately after surgery, 6 weeks after discharge 
from the hospital, and at 3 months, 6 months, 1 year, and then 
annually. Acetabular  radiolucent  lines  and  osteolysis  were 
measured  according  to  the  zones  described  by  DeLee  and 
Charnley. Radiographic loosening of the cup was defined as 
the presence of radiolucent lines measuring 2 mm in at least 
two DeLee-Charnley zones, axial cup migration of > 5 mm, 
or > 5° of change in cup inclination on the anteroposterior 
radiographs of the pelvis. 
On the femoral side, we assessed the presence and pro-
gression of radiolucent lines according to Gruen et al., calcar 
resorption or atrophy, subsidence, periprosthetic osteolysis, 
and cortical hypertrophy. Loosening of the stem was defined 
as migration exceeding 3 mm or a continuous radiolucent line 
wider than 2 mm. Radiographic measurement of wear was not 
possible as no distinction could be made between the edge 
of the femoral head and the metal articulation surface of the 
acetabular component.
Serum ion determination
Titanium, cobalt, and chromium ion measurements were per-
formed in all patients. None of the patients had renal insuffi-
ciency or chromium and cobalt devices of any kind that could 
create bias in the serum metal determinations. Blood samples 
were taken just before implantation and 3 months, 6 months, 1 
year, and every year postoperatively until the last endpoint. To 
avoid metal contamination, blood samples were drawn using a 
sampling kit dedicated to trace element determination; this kit 
included an S-Monovette needle (ref. 85.1162.400; Sarstedt, 
Marnay, France) and lithium heparin in a 7.5-mL S-Monovette 
for trace metal analysis (ref. 01.1604.400, Sarstedt). All metal 
ion measurements were performed on 2 samples. Titanium 
was measured in diluted blood plasma by inductively coupled 
optical emission spectrometry (ICP-OES) on a JY24 spec-
trometer (Jobin Yvon, Longjumeau, France). The detection 
limit  for  titanium  was  1.4  µg/L  of  plasma.  Concentrations 
under the detection level were set at half the detection limit 
value (0.7 µg/L) to allow conventional statistical analysis. The 
serum cobalt and chromium levels were also determined in the 
same serum samples. Until 2004, these concentrations were 
simultaneously determined by electrothermal atomic absorp-
tion spectrometry using a 5100 spectrometer, and thereafter 
by using a SIMAA 6100 spectrometer (Perkin Elmer, Court-
abœuf,  France).  In  our  laboratory,  the  detection  limits  of 
cobalt and chromium in serum were 0.3 µg/L. Concentrations 
below that level were defined as 0.15 µg/L to allow statisti-
cal analysis. As an internal quality control, Seronorm levels I 
and II (Sero, distributed by Ingen, Rungis, France) were also 
determined in each analytical session.
Statistics 
All statistical analyses were performed using SAS 9.1 soft-
ware (SAS institute, Cary, NC). Prosthesis survival analysis 
was calculated using the Kaplan-Meier method with exchange 
of the cup, the stem, or both components as endpoint. 
Our study included 25 bilateral joint replacements, and the 
events of these cannot be considered statistically independent. 
The statistical methods used required independent observa-
tions, however. Thus, we included only randomized observa-
tions from 1 hip of each patient in all statistical tests.170  Acta Orthopaedica 2009; 80 (2): 168–173
Serum metal levels were expressed as medians with twenty-
fifth and seventy-fifth percentiles (IQR). Normally distributed 
data were analyzed with t-tests or ANOVA, and non-paramet-
ric data were analyzed with the Mann-Whitney U test. 
Cups were categorized as either small (44–50 mm) or large 
(52–60  mm).  Chi-square  tests  were  performed  to  compare 
patients  with  and  without  radiolucent  lines.  Fisher’s  exact 
tests were performed to compare patients with and without 
cup revision. Log-rank test was performed to determine a sur-
geon factor and whether the rate of loosening and revision was 
dependent upon surgeons. Statistical significance for all tests 
was set at p < 0.05.
Results
Clinical results
The  mean  Harris  hip  score  improved  from  39  (15–68) 
preoperatively  to  91  (83–97)  at  the  latest  follow-up 
(p < 0.05). 
Survivorship 
Considering revision for any cause as endpoint, the cumula-
tive survival rate was 89% (95% CI: 80–94) at 9 years. The 
survivorship for cup revision due to aseptic loosening was 
91% (95% CI: 82–96). With the endpoint as revision of the 
femur for aseptic loosening, the survivorship was 99% (95% 
CI: 93–100). The rates of revision and loosening were not sig-
nificantly different for the different surgeons (p > 0.3).
Complications
2 recurrent dislocations required revisions due to impinge-
ment between the titanium femoral neck and the edge of the 
Co-Cr insert of the cup. These dislocations occurred 1 month 
and 6 months after implantation. At the time of revision, the 
components were not loose; black staining of the joint space 
was noted, probably due to titanium release from femoral neck 
notches. In both cases, serum titanium levels were high due 
to release from the femoral neck lesions. All of the compo-
nents were revised with the same polished cemented stem and 
a cemented polyethylene cup. 
8 revisions were performed for loosened Metasul cemented 
cups with radiolucencies greater than 2 mm, axial migration, 
and osteolysis (Figure). 7 loosened cups were recorded in 
the unilateral group (84 hips) and the remaining one was in 
the bilateral group (50 hips). No relationship was detected 
between cup size and cup loosening (p = 0.70). Initially, all of 
the sockets had good cementing and no radiolucent lines. In 3 
of the 8 cases, the THAs were revised using MM bearing sur-
faces (2 cases) or stainless steel-on-polyethylene bearing sur-
faces (1 case). Due to the serum levels of cobalt and the mac-
roscopic metallosis observed at the time of revision, bearing 
surfaces were converted to ceramic-on-ceramic using a new 
cementless stem in 2 other revisions. In the last 3 cases, hips 
were revised using ceramic-on-ceramic heads with sleeves 
(Ceramtec, Plochingen, Germany) with conservation of the 
titanium femoral stems. 
5 years after implantation, 1 case of progressive subsidence 
due to poor cement technique required revision; only the stem 
was changed. 
1 prosthesis was revised due to persistent and unexplained 
pain; the implant was not loose. The serum cobalt level was 
more than 20-fold higher than the detection limit. At the time 
of revision, no abnormality was observed apart from massive 
and macroscopic metallosis in the joint. The bearing surfaces 
were changed for the ceramic-on-ceramic implants (the stem 
was not changed) and the symptoms disappeared.
Radiographic results
Radiolucent lines and osteolysis around the cup were observed 
Progressive radiolucent lines at the bone-cement interface of the socket, leading to aseptic loosening at the 7-year follow-up. A. After one year. 
B. After 5 years. C. At the 7-year follow-up.
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in 26% of the hips (35/134). They were all located at the bone-
cement interface, beginning always in zone 1—early and pro-
gressing with time. 5 of these 35 cups were considered loose 
due to there being radiolucent lines more than 2 mm and occu-
pying at least 2 zones of DeLee et Charnley. 
No relationship could be found between the occurrence of 
the radiolucent lines and cup size, cup and femoral position 
(cup inclination and anteversion, femoral anteversion, offset), 
body mass index, or Devane activity score. 
3  stem  subsidences  were  recorded  as  being  due  to  poor 
cementing technique. 2 were inferior to 5 mm and slowly 
changed with time; these may require revision in the future. 
The third was revised as previously mentioned. It was associ-
ated with osteolysis in Gruen zone 6. Non-progressive femoral 
radiolucent lines were present in zone 1 at the cement-pros-
thesis interface in 10 hips, and had spread into zone 7 in 6 
more hips. We did not observe femoral hypertrophic reaction 
around the distal stem, or calcar resorption. 
Serum levels of metals
In the 84 patients with unilateral MM hip replacements, the 
median serum cobalt level was relatively constant at 5- to more 
than 6-fold greater than the 0.3 µg/L detection limit (Table 1). 
Thus, serum cobalt levels did not increase over time, as found 
by Brodner et al. (2003). The median serum cobalt level was 
1.4 µg/L at 1 year, 1.7 µg/L at 3 years (the highest median 
level), 1.3 µg/L at 5 years, and 1.6 µg/L at 9 years. The high-
est level of serum cobalt, 47 µg/L, was detected in 1 of the 
2 patients with recurrent early dislocation and impingement 
between the titanium taper and the Co-Cr acetabular articula-
tion. The highest level of serum titanium, 61 µg/L, was also 
detected in this patient. In the group of 8 patients whose hip 
prostheses  were  revised  for  aseptic  loosening,  the  median 
serum cobalt level was 26 µg/L (0.95–34) just before surgery. 
The median serum titanium and chromium levels were also 
relatively constant (Table 1). 
In the 25 patients with bilateral MM hip replacements, the 
cobalt serum levels were always higher than in the unilateral 
group but only significant (p < 0.05) at 3 and 5 years. Regard-
ing chromium, the values were also always higher than in the 
unilateral group but they were significant (p < 0.05) at 3, 5, 
and 7 years (Table 2). 
The median titanium concentration stayed within a constant 
range,  and  the  median  value  was  always  below  the  detec-
tion limit of 1.40 µg/L (Table 1). In contrast, patients whose 
implants  had  failed  stems  had  the  highest  titanium  serum 
levels in the series at the time of failure; these levels ranged 
from 9.1 to 60 µg/L and were much higher than the detec-
tion level. For patients with loosened cups, the titanium serum 
levels remained below the limit of detection. 
In the bilateral group, titanium serum levels were also con-
stant and always below the detection limit.
Discussion
Our  findings  in  this  study  of  MM-backed  polyethylene 
cemented hip arthroplasties with 28-mm femoral heads raise 
serious concerns. The survivorship at 9 years with revision 
due to aseptic cup loosening was 91%. In a study with 10-
year follow-up based on the Swedish Hip Arthroplasty regis-
ter (Malchau et al. 2002), the survivorship was 93% for any 
revision with cemented metal-on-polyethylene. We observed 
early and progressive radiolucent lines and osteolysis in 26% 
Table 1. Serum levels (median and IQR) of cobalt, chromium, and titanium (in μg/L) in the unilateral metal-on-metal hip replacements group 
    1 year   3 years   5 years   7 years   9 years
No. of patients   84   84   84   84   56
Cobalt a  1.41 (1.04–2.78)  1.69 (1.04–2.46)  1.30 (1.01–2.01)  1.69 (1.12–3.28)  1.55 (1.05–2.79)
Chromium a  2.18 (1.49–3.37)  2.05 (0.94–3.21)  1.70 (0.90–3.41)  1.42 (0.80–2.25)  1.49 (0.72–2.0)
Titanium b  0.70 (0.70–0.70)  0.70 (070–0.81)  0.70 (0.70–070)  0.70 (0.70–1.96)  0.70 (0.70–1.61)  
a In our laboratory, the detection limit of cobalt and chromium in serum was 0.30 μg/L. 
   Concentrations below that limit were defined as 0.15 μg/L.
b The detection limit for titanium was 1.40 μg/L of plasma. 
   Concentrations under the detection limit were set at half the detection limit value (0.70 μg/L).
Table 2. Serum levels (median and IQR) of cobalt, chromium, and titanium (in μg/L) in the bilateral metal-on-metal hip replacements group 
  1 year   3 years   5 years  7 years   9 years
No. of patients   25   25   25   25   15
Cobalt  1.69 (1.13–4.66)  2.33 (1.66–4.15)  2.82 (1.65–4.69)  1.89 (1.35–3.65)  2.03 (1.09–4.82)
Chromium  2.60 (1.45–5.52)  2.61 (1.45–5.64)  2.83 (1.81–5.48)  2.41 (1.73–4.48)  2.99 (1.97–4.40)
Titanium   0.70 (0.70–0.85)  0.70 (0.70–1.62)  0.70 (0.70–0.80)  0.70 (0.70–2.16)  0.80 (0.70–1.83)   
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of the cups, which raises questions about their durability. At 
the endpoint of this study, 5 additional cups were considered 
loosened and required revision.
With the use of cemented MM arthroplasties, radiolucent 
lines have been described in the literature during the early 
postoperative period. However, their long-term evolution has 
remained unclear (Weber 1996, Levai et al. 2006, Nich et al. 
2006). In a study of cemented Metasul cups, Levai et al. (2006) 
reported a high frequency of acetabular radiolucent lines; 5-
year survivorship using surgical revision as the endpoint for 
aseptic cup loosening was 94%. The thickness of polyethylene 
has been suggested as an explanation for these results (Levai 
et al. 2006, Nich et al. 2006). Thinner polyethylene may lead 
to increased socket rigidity, resulting in greater constraints at 
the bone-cement interface; indeed, this has been observed with 
other types of rigid cemented cups (Nich et al. 2003). 
We found no relationship between the occurrence of the 
acetabular radiolucencies or revisions and cup size or implant 
position.  Moreover,  osteolysis  was  found  to  be  associated 
with  progressive  radiolucencies,  as  already  reported  for 
other second-generation MM implants, including cementless 
implants (Park et al. 2005, Grubl et al. 2007). There may be 
additional factors to explain the rate of aseptic loosening, but 
metal debris from the implants most likely contributes to wear 
and corrosion (Yan et al. 2006).
Acute  dislocation  and  joint  laxity  with  subluxations  and 
microseparations  can  induce  local  and  systemic  release  of 
chromium and cobalt particles (Williams et al. 2006, Brown 
et al. 2007). Simulator studies have shown that there is a sub-
stantial  release  of  particles  when  microseparation  is  intro-
duced into the gait cycle (Williams et al. 2006). Our analysis 
of retrieved femoral heads and liners showed lesions typical of 
microseparation with stripe wear. Mapping of the stripe wear 
lesions to balls and to cup rims has indicated that this is an 
edge-contact phenomenon.
The surfaces of MM bearings release Co-Cr wear particles 
that are not biologically inert (Willert et al. 1996). In vitro 
studies have shown production of the bone-resorbing cyto-
kines TNF-α and IL-1 by cells cultured in the presence of Co-
Cr particles (Catelas et al. 2004). Light microscopy has shown 
that small metal wear particles can aggregate into larger bioac-
tive particles and that they can induce osteolysis and aseptic 
loosening (Catelas et al. 2004, Brown et al. 2007). In addition 
to the possible adverse effects of Co-Cr particles derived from 
the bearing surface, the effects of titanium particles should 
also be considered (Haynes et al. 1993). We used cemented 
femoral titanium (Ti–6Al–4V) stems in combination with the 
MM bearing surface, which is a controversial choice. It has 
been suggested that cemented titanium stems may result in 
micromotion, corrosion, and production of metal debris, lead-
ing to aseptic loosening (Scholl et al. 2000). In addition, tita-
nium debris may be generated at the metal head/neck modu-
lar junction. We did not find any evidence to support these 
hypotheses, however. First of all, the performance of the stem 
was excellent, with 99% survivorship at the last review; these 
results are in accordance with the results of previously pub-
lished studies (Nich et al. 2003, Boyer et al. 2008). The only 
elevated serum titanium levels were the result of stem loos-
ening due to poor cementing technique or to neck impinge-
ment (in the 2 cases of dislocation). In all other patients, serum 
titanium levels were always below the limit of detection (1.4 
µg/L), even for patients with revisions due to cup loosening. 
In these cases, peroperative examination of the taper did not 
reveal any significant corrosion, fracturing, or crevicing. 
Particles released from the implants can also corrode in the 
biological fluid environment and generate metal ions (Bhamra 
and Case 2006). Ions released from MM THAs have been 
detected by analysis of serum samples, whole blood, and eryth-
rocytes (Brodner et al. 2003, Rasquinha et al. 2006). Most of 
these studies found cobalt concentrations around 1.0–1.5 µg/L 
that remained constant. In addition, the cobalt levels were 8- 
to 10-fold higher than the detection limit and did not reflect 
the changes in wear, which were described as involving 2 suc-
cessive phases (Brodner et al. 2003). Our results, at a mean 
of 9-years follow-up, were in agreement with those of earlier 
studies: median serum cobalt levels were 1.41 µg/L after 1 
year and 1.55 µg/L at the endpoint of the study.
Metal ions released from implants can activate the immune 
system by forming metal-protein complexes, which can in turn 
induce implant-related hypersensitivity reactions with delayed 
cell-mediated  responses  (Hallab  et  al.  2001).  Park  et  al. 
(2005) described 9 patients with early osteolysis of the greater 
trochanter after cementless metal-on-metal hip replacement. 
Their data supported a role for hypersensitivity, as histologi-
cal analysis revealed periprosthetic tissue infiltration of CD3-
positive T-cells and CD68-positive macrophages; immunohis-
tochemical analysis showed cytokines IL-1 and TNF-α. 
In conclusion, the results of this prospective series of 28-
mm  MM-backed  polyethylene  cemented  hip  arthroplasties 
were disappointing, and these implants were inferior to metal-
on-polyethylene implants with the same femoral head diam-
eter (Malchau et al. 2002). Constraints at the cement-bone 
interface may be involved due to the sandwich structure of 
cemented MM cups (Nich et al. 2003). Titanium stems do not 
appear to have played a role in implant failure. The release 
of metal particles and ions from the bearing surfaces may 
also have ramifications, such as induction of delayed reaction 
against the implants. Because of the high rate of acetabular 
loosening (with 91% survivorship at 9 years), we no longer 
use bearings with metal-on-metal surfaces.
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